-
Oil companies close in on Venezuela despite hurdles
-
Romanian parliament rejects pro-EU PM candidate
-
Turkey freezes ex-minister's assets as fund scandal grows
-
Court halts Tennessee's first execution of woman in 200 years
-
Guardiola backs Man City after bombshell guilty verdicts
-
Israelis march between once-closed West Bank settlements
-
G20 trade ministers open talks under strain of Trump tariffs
-
'Welcome back,' says Macron, as UK PM opens door to EU return
-
France in talks with UK to end 2025 migrant accord: ministry
-
Israel PM says pilot of rerouted flight tried to crash plane
-
Europe's surging inflation spreads gloom in stock markets
-
Demuro hopes to deliver Japan a 'magical' Arc victory
-
Truth commission demands compensation for Sweden's Sami people
-
'Devastated' AI scandal author Orelien returns to Quebec
-
Japan win marathon penalty shootout to set up South Korea gold-medal clash
-
US reports firm Q2 economic growth, inflation steady
-
Djokovic grinds out opening-round win at China Open
-
Energy costs spark inflation surge across Europe
-
Northern Ireland police probe blockade of disputed parade
-
Parma appoint Italy World Cup winner Gilardino
-
UK PM Burnham reopens divisive debate on rejoining EU
-
West Indies pile up record 405-7 in second ODI against India
-
Man City future in doubt after guilty verdict
-
Romanian parliament rejects pro-EU PM candidate amid political deadlock
-
'Do something,' begs Iranian woman after death sentence over protests
-
Passenger on rerouted flydubai flight says pilot tried to crash plane
-
China extends 52-year unbeaten record as Games organisers say sorry
-
Russia targets Kyiv power supply as freezing winter approaches
-
In Manchester, people say City scandal is 'shame for football'
-
Haze pushes Kuala Lumpur, Singapore into world's most polluted cities
-
Stocks lacklustre as inflation data weighs on sentiment
-
Dangote's $16bn Kenya refinery 'new chapter' for Africa
-
Israel-bound plane rerouted, pilots wounded in reported fight
-
Ireland coach Hallgrimsson confirms second Israel game will go ahead
-
Truth commission on Sweden's Sami people seeks redress
-
Swift concert attack plan convict fails to get Disney damages
-
Energy costs spark inflation surges in France, Italy
-
Ocon to leave Haas at end of F1 season
-
South Korea break China hearts to reach Asian Games football final
-
Indonesia razes poolside prison 'villas' where whisky, TVs seized
-
Eala storms into Asian Games semi-finals to thrill adoring fans
-
Japan court rules human voice is protected in TikTok AI case
-
Turkey freezes ex-minister's assets as fund crisis grows
-
French inflation jumps to 3% in September on energy costs
-
What we know about the North Korean POW dispute
-
South Korea score late to reach Asian Games football final
-
Most equities rise after oil price plunge, US data in focus
-
Tom Kim defies jet-lag, Kho cards ace as Asian Games golf begins
-
Polar oceans transformed as warming melts ice habitats: research
-
Thai teen rocker Nene aims to tour, write music... and return to school
France warns against weight loss supplements using Garcinia plant
France warned Wednesday against dietary supplements promising weight loss that use the tropical plant Garcinia cambogia after a range of rare but serious side effects including one death were reported.
Garcinia cambogia -- which is also called Garcinia gummi-gutta or Malabar tamarind -- grows in India and Southeast Asia and has a fruit that looks like a pumpkin.
A range of supplements are sold around the world using extracts from the plant advertising its ability to suppress appetite and drive weight loss -- claims not backed by comprehensive scientific evidence.
After investigating the death of a person who took a Garcinia-based supplement -- and looking at other side effects reported in the United States and elsewhere -- French food safety agency ANSES said it "strongly advises" people against consuming the plant.
The plant has been banned from being used medicine since 2012 in France, but continues to be advertised in more 340 dietary supplements, which are mostly available online, the agency said in a statement.
There were 38 cases of serious side effects affecting the liver, pancreas, heart, muscles and mental health reported in France between 2009 and March last year, ANSES said.
These side effects can affect people with a history of psychiatric disorders, pancreatitis or hepatitis -- or who suffer from diabetes, obesity or high blood pressure, the agency added.
People taking antidepressants, antiretrovirals or drugs that affect the liver can also experience side effects.
A 71-year-old woman in France taking blood pressure drugs died of acute hepatitis in 2019 after taking Garcinia-based supplement Slim Metabol. ANSES says her death was "very likely" linked to the supplement, which remains on sale.
However people without a history of health problems can also be affected.
"A 32-year-old woman with no medical history developed myocarditis that led to her requiring a heart transplant," Aymeric Dopter, head of the ANSES nutrition risk assessment unit, told AFP.
"Some people will tell you: 'I took it and I am fine'," Dopter said.
"But we can see from these few cases that people who were simply trying to lose weight ended up with seriously impaired health -- or even died," he said.
"It is not the worth the risk."
The safety of products using Garcinia cambogia is currently being assessed by the European Food Safety Agency.
The watchdog is also investigating the risk of hydroxycitric acid, an ingredient extracted from the Garcinia plant's fruit, which is also used in supplements promoting weight loss.
France's ANSES called for the list of plants authorised for use in food supplements to be "harmonised" across the European Union.
A.Motta--PC